logo
logo
Sign in

The Transcranial Magnetic Stimulator Market Is Estimated To Witness High Growth Owing To Improved Accessibility And Increasing Adoption Of Neuropathic Disorders Treatments

avatar
gauri kanale
  The Transcranial Magnetic Stimulator Market Is Estimated To Witness High Growth Owing To Improved Accessibility And Increasing Adoption Of Neuropathic Disorders Treatments


The transcranial magnetic stimulator market is estimated to be valued at US$ 638.4 Mn in 2023 and is expected to exhibit a CAGR of 12.4% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Transcranial magnetic stimulator (TMS) is a non-invasive technique used for stimulating small areas of the brain by means of focussing intense and brief magnetic field impulses on the region of interest. The device consists of a stimulating coil, which produces short magnetic pulses when electric current is passed through it. It is generally used in treatment of neuropathic disorders such as major depressive disorder, schizophrenia, addiction disorders, Alzheimer's disease and Parkinson's disease among others. TMS therapy is gaining popularity as an alternative to pharmacological and surgical treatments owing to its safety and effectiveness.

Market Dynamics:

Rising prevalence of neuropathic disorders across the globe is a key driver augmenting growth of the TMS market. According to WHO, around 450 million people suffer from such disorders globally. In addition, improving accessibility of TMS devices major healthcare facilities worldwide is expected to boost adoption. Moreover, increasing R&D investments by manufacturers in development of innovative and portable TMS devices is anticipated to offer lucrative opportunities over the forecast period. However, high costs associated with TMS procedures and lack of trained professionals may limit market growth to some extent.

Segment Analysis

The global Transcranial Magnetic Stimulator Market Size is divided into three key segments based on application - Diagnostics & Research, Therapy, and Others. Among these, the Therapy segment currently dominates with the largest market share owing to the increasing usage of rTMS technology for the treatment of various neurological and psychiatric disorders such as depression. This non-invasive therapy has shown positive results and fewer side effects as compared to medication.

PEST Analysis

Political: Governments across various countries are supporting the use of alternative treatment options for mental health disorders due to growing awareness. They are approving policies to promote the adoption of novel medical devices like TMS.

Economic: The rising healthcare expenditure to deal with the growing prevalence of neurological conditions and the presence of favorable reimbursement schemes are fueling the market growth economically.

Social: Growing social acceptance of brain stimulation therapies and reductions in stigma associated with mental illnesses are propelling their demand.

Technological: Continuous R&D investments by players have led to rapid technological advancements in TMS devices. The introduction of multi-coil rTMS devices and devices integrated with neuronavigation systems has further widened their clinical applications.

Key Takeaways

The global Transcranial Magnetic Stimulator market size is expected to reach US$ 638.4 Mn in 2023, expanding at a high CAGR of 12.4% during 2023 - 2030. The growth can be attributed to the rising geriatric population who are prone to neurological disorders and increasing adoption of rTMS for mental health conditions.

Regionally, North America captures the highest market share currently owing to advanced healthcare infrastructure and rising prevalence of neuropsychiatric diseases in the region. However, Asia Pacific is expected to witness the fastest growth over the forecast period backed by improving access to novel brain stimulation therapies and growing medical tourism in the region.

Key players operating in the Transcranial Magnetic Stimulator market are Magstim, Brainsway, Nexstim, Neuronetics, Remed, Yiruide, Dr. Langer Medical, MAG & More, Deymed, MagVenture, eNeura, Neurosoft, Neuro-Electrics, TCT Research, MagPro Compact, Axilum Robotics, Onward Medical and Rogue Resolutions. They are focusing on new product launches, geographical expansions and strategic collaborations to strengthen their market presence.

 

Read More: https://www.rapidwebwire.com/transcranial-magnetic-stimulator-market-demand/


collect
0
avatar
gauri kanale
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more